Abstract:There have been more than 2.2 million confirmed cases and over 120 000 deaths from the human coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), in the United States alone. However, there is currently a lack of proven effective medications against COVID-19. Drug repurposing offers a promising route for the development of prevention and treatment strategies for COVID-19. This study reports an integrative, network-based deep-learning methodology to identify repurposable drugs for COVID-19 (termed CoV-KGE). Specifically, we built a comprehensive knowledge graph that includes 15 million edges across 39 types of relationships connecting drugs, diseases, proteins/genes, pathways, and expression from a large scientific corpus of 24 million PubMed publications. Using Amazon's AWS computing resources and a network-based, deep-learning framework, we identified 41 repurposable drugs (including dexamethasone, indomethacin, niclosamide, and toremifene) whose therapeutic associations with COVID-19 were validated by transcriptomic and proteomics data in SARS-CoV-2-infected human cells and data from ongoing clinical trials. Whereas this study by no means recommends specific drugs, it demonstrates a powerful deep-learning methodology to prioritize existing drugs for further investigation, which holds the potential to accelerate therapeutic development for COVID-19.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jproteome.0c00316?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00316</a>.Supplementary Figure 1. Diagram illustrating the prioritization of drugs based on their distance to COVID-19 in the treatment relation space. Supplementary Table 1. Details of the five categories of relationships in our KG. Supplementary Table 2. Statistics of nodes (entity) and edges (relation) in our KG (<a class="ext-link" href="/doi/suppl/10.1021/acs.jproteome.0c00316/suppl_file/pr0c00316_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Deep Learning Driven Drug Discovery: Tackling Severe Acute Respiratory Syndrome Coronavirus 2

Deep Learning for Drug Discovery: A Study of Identifying High Efficacy Drug Compounds Using a Cascade Transfer Learning Approach

A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism

Predicting drug-Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2

Deep learning for drug repurposing: Methods, databases, and applications

Deep Learning-Based Molecular Dynamics Simulation for Structure-Based Drug Design Against SARS-CoV-2

A Deep Learning Ensemble Approach to Prioritize Antiviral Drugs Against Novel Coronavirus SARS-CoV-2 for COVID-19 Drug Repurposing

Large-scale deep learning identifies the antiviral potential of PKI-179 and MTI-31 against coronaviruses

Staying Ahead of the Game: How SARS-CoV-2 has Accelerated the Application of Machine Learning in Pandemic Management

Drug Repositioning for SARS-CoV-2 Based on Graph Neural Network.

Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model

De Novo Drug Design Against SARS-CoV-2 Protein Targets Using SMILES-based Deep Reinforcement Learning.

A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2

Deep Learning Techniques and COVID-19 Drug Discovery: Fundamentals, State-of-the-Art and Future Directions

Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines

MCCS: a Novel Recognition Pattern-Based Method for Fast Track Discovery of Anti-Sars-cov-2 Drugs

Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design

IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development.

A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2

Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning

Recent advances in small-molecular therapeutics for COVID-19